Post-marketing Carcinogenicity Study of Bupropion.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Antidepressants; Bupropion; Serotonin uptake inhibitors; Tricyclic antidepressants
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 07 Jun 2017 Biomarkers information updated
- 09 Feb 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.